Estrogen and progesterone receptors in ovarian neoplasms. 1983

L C Ford, and J S Berek, and L D Lagasse, and N F Hacker, and Y Heins, and F Esmailian, and R S Leuchter, and R J DeLange

The cytoplasmic receptors for 17 beta-estradiol (ER) and progesterone (PR) were measured in 39 malignant and 15 benign ovarian neoplasms. All eight endometroid carcinomas had positive ER sites, one-half contained PR. The number of ER binding sites decreased as tumor grade increased. Conversely, none of the 11 mucinous tumors contained either ER or PR receptors. One-half of the well-differentiated serous tumors had ER (57 +/- 23 fmole/mg protein) while none of the poorly differentiated tumors had measurable binding. In serous carcinomas, PR was only detected in well-differentiated lesions (447 +/- 240 fmole/mg protein). Only one of 15 benign neoplasms contained ER and PR receptors. Correlation of tumor grade and type may help to plan hormonal therapies in advanced ovarian malignancies.

UI MeSH Term Description Entries
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010051 Ovarian Neoplasms Tumors or cancer of the OVARY. These neoplasms can be benign or malignant. They are classified according to the tissue of origin, such as the surface EPITHELIUM, the stromal endocrine cells, and the totipotent GERM CELLS. Cancer of Ovary,Ovarian Cancer,Cancer of the Ovary,Neoplasms, Ovarian,Ovary Cancer,Ovary Neoplasms,Cancer, Ovarian,Cancer, Ovary,Cancers, Ovarian,Cancers, Ovary,Neoplasm, Ovarian,Neoplasm, Ovary,Neoplasms, Ovary,Ovarian Cancers,Ovarian Neoplasm,Ovary Cancers,Ovary Neoplasm
D011960 Receptors, Estrogen Cytoplasmic proteins that bind estrogens and migrate to the nucleus where they regulate DNA transcription. Evaluation of the state of estrogen receptors in breast cancer patients has become clinically important. Estrogen Receptor,Estrogen Receptors,Estrogen Nuclear Receptor,Estrogen Receptor Type I,Estrogen Receptor Type II,Estrogen Receptors Type I,Estrogen Receptors Type II,Receptor, Estrogen Nuclear,Receptors, Estrogen, Type I,Receptors, Estrogen, Type II,Nuclear Receptor, Estrogen,Receptor, Estrogen
D011980 Receptors, Progesterone Specific proteins found in or on cells of progesterone target tissues that specifically combine with progesterone. The cytosol progesterone-receptor complex then associates with the nucleic acids to initiate protein synthesis. There are two kinds of progesterone receptors, A and B. Both are induced by estrogen and have short half-lives. Progesterone Receptors,Progestin Receptor,Progestin Receptors,Receptor, Progesterone,Receptors, Progestin,Progesterone Receptor,Receptor, Progestin
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

L C Ford, and J S Berek, and L D Lagasse, and N F Hacker, and Y Heins, and F Esmailian, and R S Leuchter, and R J DeLange
December 1983, Geburtshilfe und Frauenheilkunde,
L C Ford, and J S Berek, and L D Lagasse, and N F Hacker, and Y Heins, and F Esmailian, and R S Leuchter, and R J DeLange
April 1981, JAMA,
L C Ford, and J S Berek, and L D Lagasse, and N F Hacker, and Y Heins, and F Esmailian, and R S Leuchter, and R J DeLange
February 1990, Cancer,
L C Ford, and J S Berek, and L D Lagasse, and N F Hacker, and Y Heins, and F Esmailian, and R S Leuchter, and R J DeLange
January 1985, Jugoslavenska ginekologija i perinatologija,
L C Ford, and J S Berek, and L D Lagasse, and N F Hacker, and Y Heins, and F Esmailian, and R S Leuchter, and R J DeLange
June 2004, Molecular and cellular endocrinology,
L C Ford, and J S Berek, and L D Lagasse, and N F Hacker, and Y Heins, and F Esmailian, and R S Leuchter, and R J DeLange
October 1990, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica,
L C Ford, and J S Berek, and L D Lagasse, and N F Hacker, and Y Heins, and F Esmailian, and R S Leuchter, and R J DeLange
February 1986, Gynecologic oncology,
L C Ford, and J S Berek, and L D Lagasse, and N F Hacker, and Y Heins, and F Esmailian, and R S Leuchter, and R J DeLange
October 1983, Gynecologic oncology,
L C Ford, and J S Berek, and L D Lagasse, and N F Hacker, and Y Heins, and F Esmailian, and R S Leuchter, and R J DeLange
June 1992, Minerva ginecologica,
L C Ford, and J S Berek, and L D Lagasse, and N F Hacker, and Y Heins, and F Esmailian, and R S Leuchter, and R J DeLange
September 1989, Hua xi yi ke da xue xue bao = Journal of West China University of Medical Sciences = Huaxi yike daxue xuebao,
Copied contents to your clipboard!